Home » Topics » Regulatory

Regulatory
RSS

TheraTech joins forces with Meiji and Sankyo to develop and market oxybutynin patch

Oct. 10, 1997

Pamidronate evaluated as potential therapy for bone cancer

Oct. 9, 1997

Celgene studies chirally pure mexiletine for relief of neuropathic pain

Oct. 9, 1997

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Geref cleared for pediatric growth disorders in U.S.

Oct. 8, 1997

First approval for Infergen

Oct. 8, 1997

Knoll receives FDA approval for Vicoprofen

Oct. 7, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Oct. 7, 1997

Nasonex Nasal Spray cleared for marketing in U.S.

Oct. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026